Cell Therapy Packaging Market

Cell Therapy Packaging Market by Type of Therapy, Package Engineering Design, Scale of Operation and Geography (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, 2021-2030

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    399

  • Pages
    180

  • View Count
    10099

Cell Therapy Packaging Market Overview

The cell therapy packaging market is estimated to be worth $221 million in 2021 and is expected to grow at CAGR of 19% during the forecast period. Given their ability to treat a wide range of clinical conditions, advanced therapy medicinal products, including cell and gene therapies, have revolutionized the delivery of healthcare. Presently, more than 30 cell-based therapy products have received marketing approvals across various geographies, while more than 1,000 therapeutic candidates are under clinical evaluation. Considering the lucrative investment opportunity within cell therapy packaging market, several investors are actively supporting ongoing / future product development programs in this upcoming field of pharmacological interventions. In fact, there has been a 240% increase in investment activity,  in terms of capital amount invested, between 2019 and 2020. However, the ultimate success of cell therapies is dependent on the safe and timely delivery of viable doses of therapeutic cells to the right patient. In this context, it is worth highlighting that drug product manufacturing, packaging and logistics operations involving cell therapies are both complex and challenging. Moreover, in order to ensure the stability of such products across the supply chain, specific temperature conditions (cryogenic, ambient or refrigerated) are required, in addition to specialized packaging material. Considering that most cell therapies are personalized, it is imperative that errors in labeling are avoided at all costs. 

Context of Cell Therapy Packaging Market List of Cell Therapy Packaging Service Providers in Cell Therapy Packaging Market Market Landscape and Market Trends in Cell Therapy Packaging Market

Given the need for costly and specialized equipment and the complexities associated with handling cell-based therapy products, innovators in the healthcare industry are likely to involve contract service providers for their drug product production, packaging and transportation requirements. Over time, regulators across the world, including the US Food and Drug Administration (FDA) and the International Air Transport Association (IATA), have established guidelines for the packaging, storage and transport of cell therapies. Since CMOs / CDMOs with the necessary capabilities to handle cell therapies are also likely to have established processes that comply with the current acceptable standards across different global regions, it is better for therapy developers to strategically partner with the aforementioned players instead of focusing on developing in-house capabilities. Presently, close to 60 companies claim to be offering cell therapy packaging services and associated products.  In fact, it is estimated that close to 30% of drug substance and drug product related operations of advanced therapy medicinal products are already outsourced to capable CMOs / CDMOs. Further, over the last few years, several service providers have also forged strategic alliances among themselves, in order to further expand existing capabilities and augment their respective service offerings. Given the rising trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios, we believe that the cell therapy packaging market is likely to witness a steady market growth during the forecast period.

Key Companies in Cell Therapy Packaging Market 

Examples of key companies engaged in cell therapy packaging market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Almac, Catalent Pharma Solutions, Yourway, Lufthansa Cargo, Saint-Gobain Life Sciences, Thermo Fisher Scientific and West Pharmaceutical Services. This market report includes an easily searchable excel database of all the companies providing cell therapy packaging products and services, worldwide.

Recent Developments in Cell Therapy Packaging Market:

Several recent developments have taken place in the field of cell therapy packaging market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.

  • In July 2023, Charles River Laboratories launched lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the challenges associated with plasmid sourcing in cell and gene therapies.

Scope of the Report

The “Cell Therapy Packaging Market by Type of Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies and Other ATMPs), Package Engineering Design (Primary and Secondary Packaging), Scale of Operation (Clinical and Commercial) and Geography (North America, Europe, Asia Pacific and Rest of the World) , 2021-2030” market report features an elaborate study of the current market landscape, market size, market share, market forecast, market outlook and future opportunities of the cell therapy packaging market. In addition, the market research report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in cell therapy packaging market.  

List of Cell Therapy Packaging Product Providers in Cell Therapy Packaging Market Company Competitiveness Analysis in Cell Therapy Packaging Market Partnerships and Collaborations Analysis in Cell Therapy Packaging Market

Amongst other elements, the market research report includes:

  • An overview of the current market landscape of cell therapy packaging services providers, including a detailed analysis based on their year of establishment, company size, location of headquarters, package engineering design (primary and secondary), type of packaging (active and passive), packaging material (dry ice and liquid nitrogen),  type of passive system used, temperature ranges supported, type of cells handled and additional services offered. 
  • A detailed assessment of the current market landscape of cell therapy packaging products, providing information on type of packaging container (bags, vials, shipping container and others), container fabrication material (plastic and others), storage temperature conditions, type of cells packed and usability of containers. In addition, the chapter highlights analysis of cell therapy packaging product provider(s), based on various parameters such as year of establishment, company size and location of headquarters and key players.
  • An in-depth competitiveness analysis of cell therapy packaging service providers based in different geographies, by taking into consideration the service strength of a company (based on its experience), packaging portfolio (package engineering design, type of packaging, type of packaging material and temperature ranges supported) service portfolio (type of additional services offered) and company size (small, mid-sized and large companies).
  • An analysis of the various partnerships established between cell therapy packaging providers and cell therapy developers, during the period, 2016-2021. It includes a brief description of various types of partnership models (namely service alliance, technology / platform integration agreement, merger and acquisition) adopted by stakeholders engaged in cell therapy packaging market. It is worth mentioning that the data captured during our research was analyzed based on several parameters, such as year of partnership, type of partnership, purpose of partnership, type of service covered and geographical location of players involved in a partnership.
  • A list of more than 250 cell therapy developers anticipated to partner with cell therapy packaging providers, which have been shortlisted on the basis of developer strength (based on company size), type of therapy and pipeline maturity (based on stage of development of drug candidate).
  • A case study highlighting the companies that claim to have the required expertise and capabilities for development and manufacturing of cell therapies, along with the information on their year of establishment, company size, location of headquarters and location of manufacturing facility. In addition, the chapter presents analysis on type of cells manufactured, source of cells, scale of operation and manufacturing capabilities / services of the aforementioned companies.
  • Detailed profiles of the key players offering cell therapy packaging services and products. Each profile includes a brief overview of the company, details on cell therapy service portfolio, information on cell therapy packaging product portfolio, recent developments and an informed future outlook.

The key objective of cell therapy packaging market report is to provide a detailed market analysis in order to estimate the existing market size, market value, statistics and future opportunity for cell therapy packaging market during the forecast period. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, for the forecast period 2021-2030. Our year-wise projections of the current and future opportunity have further been segmented across [A] type of therapy (T-cell therapies, dendritic cell vaccines, stem cell therapies, NK cell therapies and other advanced therapy medicinal products), [B] package engineering design (primary and secondary packaging), [C] scale of operation (clinical and commercial) and [D] geography (North America, Europe, Asia Pacific and Rest of the World)

Potential Strategic Partners in Cell Therapy Packaging Market Geographical Distribution of Cell Therapy Manufacturers in Cell Therapy Packaging Market Market Forecast and Opportunity Analysis in Cell Therapy Packaging Market

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this market research report are in USD, unless otherwise specified.

Frequently Asked Questions

Question 1: What is cell therapy packaging?

Answer: Cell therapy packaging materials are special grade products which are specifically designed for containing cell or gene therapies. These products are inert in nature to avoid any contamination and deterioration of the therapeutic inside.

Question 2: How big is the cell therapy packaging market?

Answer: The cell therapy packaging market size is estimated to be worth $221 million in 2021.

Question 3: What is the projected market growth of the cell therapy packaging market?

Answer: The cell therapy packaging market is expected to grow at compounded annual growth rate (CAGR) of 19% during the forecast period 2021 – 2030.

Question 4: Who are the leading companies in the cell therapy packaging market?

Answer: Examples of key companies engaged in cell therapy packaging market (which have also been profiled in this market report; the complete list of companies is available in the full report) include Almac, Catalent Pharma Solutions, Yourway, Lufthansa Cargo, Saint-Gobain Life Sciences, Thermo Fisher Scientific and West Pharmaceutical Services.

Question 5: How many companies are currently engaged in the cell therapy packaging market?

Answer: Close to 60 companies are currently engaged in the cell therapy packaging market providing products and services for various cell therapies.

Question 6: How much money has been invested by stakeholders in the cell therapy market?

Answer: Over USD 20 billion has been invested by stakeholders engaged in the cell therapy market, to augment the ongoing research and development in the field.

Question 7: How many cell therapy products are approved for the market across various geographies?

Answer: Presently, more than 30 cell therapy products have received marketing approvals across various geographies, while more than 1,000 therapeutic candidates are under clinical evaluation.

PRICING DETAILS

USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the read more

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com